Ageing horses are reshaping equine care and cost: full analysis

The ageing equine population is becoming a more visible clinical and business issue for veterinary practices, as horses live longer and require more chronic, resource-intensive care. Vet Times frames the shift through both a medical and financial lens, pointing to rising demand for management of pituitary pars intermedia dysfunction, dental disease, arthritis, and age-related nutritional problems, alongside the growing cost of maintaining elderly horses. The theme is consistent with broader veterinary reporting that longer lifespans are reshaping patient populations across animal health, even if the equine model brings its own ambulatory, compliance, and cost challenges. (pubmed.ncbi.nlm.nih.gov)

This didn’t happen overnight. Better preventive care, improved nutrition, and more willingness to keep horses into retirement have all contributed to an older equine population. Earlier research from the University of Minnesota found that horses aged 20 years and older represented 2.2% of equine hospital evaluations in 1989 and 12.5% by 1999, a sharp increase over a decade. More recent survey data suggest senior horses, often defined as 15 years and older, may now make up as much as one-third of the U.S. equine population, although health and management data remain limited. (pubmed.ncbi.nlm.nih.gov)

Clinically, PPID remains one of the clearest examples of how ageing changes equine practice. The Equine Endocrinology Group, a clinician-researcher consortium that updates guidance for veterinarians, published 2025 recommendations on PPID diagnosis and management, reinforcing the condition’s central place in senior-horse care. AAEP proceedings and educational materials similarly highlight PPID, dental disease, orthopedic disease, colic, and abnormal body condition as common concerns in older horses. Vet Times’ companion coverage on nutrition adds another layer: feeding elderly horses often means increasing calories without worsening insulin dysregulation, relying on low-starch, low-sugar strategies when poor dentition, weight loss, or metabolic disease complicate intake. (equineendocrinologygroup.org)

There’s also a mounting evidence base around long-term treatment. A 2025 Journal of Veterinary Internal Medicine paper on pergolide treatment for equids with PPID adds support for sustained therapy, and related coverage has emphasized improvement in clinical signs and quality of life over time. At the same time, researchers at the University of Minnesota are recruiting horses for work on the genetic factors that may influence pergolide response and adverse effects, a sign that even established therapies still have important unanswered questions around precision treatment and compliance. (pmc.ncbi.nlm.nih.gov)

Industry and expert commentary is converging on the same point: senior-horse medicine is no longer niche. The Equine Endocrinology Group describes its role as providing recommendations to veterinarians and researchers to improve diagnosis and management of endocrine disorders, while AAEP educational resources stress that older horses need close attention to dentistry, body condition, and endocrine risk. That aligns with the practical message in Vet Times: geriatric equine care increasingly demands coordinated, preventive management rather than reactive treatment once weight loss, laminitis, or advanced dental disease are already in play. (equineendocrinologygroup.org)

Why it matters: For veterinary professionals, the ageing equine population has implications well beyond caseload mix. It affects appointment cadence, ambulatory workflow, client communication, inventory, and pricing. Older horses are more likely to need serial monitoring, multimorbidity management, and individualized feeding or medication plans, all of which take time and can strain adherence when pet parents are balancing quality-of-life goals against rising costs. In equine practice, those pressures are amplified by the economics of farm calls and by the fact that many senior horses are no longer generating sporting or breeding income, making the value conversation different from performance medicine. (cambridge.org)

The workforce and education implications are worth noting, too. As small animal medicine has built more formal senior-care pathways, equine medicine appears to be moving in the same direction, though less systematically. The literature and guidance now point toward a need for more explicit geriatric protocols covering dental exams, endocrine screening, nutrition review, parasite control, vaccination, lameness assessment, and welfare conversations. Practices that can package those services clearly may be better positioned to support continuity of care and reduce crisis-driven presentations. This is an inference based on the trend lines in the cited reporting, survey data, and professional guidance. (ivis.org)

What to watch: The next phase will likely center on earlier identification of PPID and related metabolic disease, more evidence on long-term pergolide response, and stronger practice models for delivering affordable, preventive geriatric equine care. Watch for updated endocrine guidance, additional nutrition-focused protocols, and more research on how senior-horse demographics are changing demand in ambulatory equine practice. (equineendocrinologygroup.org)